
National Association of Testing Authorities, Australia
Scope of Accreditation
BasePair Genomics
Scope of Accreditation
BasePair Genomics
ISO 15189 (2012)
Human Pathology
Service | Product | Determinant |
---|---|---|
Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Targeted genes | Buccal swabs | ABC transporters; Bilirubin-UGT enzyme; Catechol-O-methyltransferase (COMT) pharmacogenomic studies; Cytochrome P450 pharmacogenomic studies; HLA-B27; Human carboxylesterase 1 (CES1) pharmacogenomic studies; OPRM1 pharmacogenomic studies; SCL01B1 pharmacogenomic studies; VKORC1 pharmacogenomic studies; α1-Antitrypsin |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
20374
Site No.
24392
Print date
24 Jun 2022
END OF SCOPE